
Global Cancer Treatment Drugs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Cancer Treatment Drugs market size was valued at US$ 217600 million in 2024 and is forecast to a readjusted size of USD 385110 million by 2031 with a CAGR of 8.6% during review period.
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.
This report is a detailed and comprehensive analysis for global Cancer Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cancer Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cancer Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Market segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Major players covered
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Treatment Drugs, with price, sales quantity, revenue, and global market share of Cancer Treatment Drugs from 2020 to 2025.
Chapter 3, the Cancer Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cancer Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Treatment Drugs.
Chapter 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, customers, research findings and conclusion.
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.
This report is a detailed and comprehensive analysis for global Cancer Treatment Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cancer Treatment Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Pcs), and average selling prices (USD/Pcs), 2020-2031
Global Cancer Treatment Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Pcs), and ASP (USD/Pcs), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Treatment Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Treatment Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Novartis, Celgene, Bristol-Myers Squibb, Amgen, Johnson & Johnson, Pfizer, Takeda, Eli Lilly, AstraZeneca, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Cancer Treatment Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Market segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Major players covered
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Treatment Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cancer Treatment Drugs, with price, sales quantity, revenue, and global market share of Cancer Treatment Drugs from 2020 to 2025.
Chapter 3, the Cancer Treatment Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Treatment Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Cancer Treatment Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cancer Treatment Drugs.
Chapter 14 and 15, to describe Cancer Treatment Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
160 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Cancer Treatment Drugs by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.